SCF ENCYCLOPEDIA ENTRY

PRIMARY POSTPARTUM HEMORRHAGE (PPH)

SCF-RDOS Registry Code: SCF-RDOS-PPD-HM-001

Disease Type Classification: Hematologic and Obstetric Emergency → Postpartum Hemorrhagic Disorder → Primary Postpartum Hemorrhage Syndrome

Adaptive Module Activation:

Universal Core Module
Hematologic Disease Expansion
Vascular Injury Expansion
Obstetric Emergency Expansion
Coagulation System Expansion
Endothelial Dysfunction Expansion
Multiorgan Perfusion Expansion

1. SCOPE & POSITIONING

Etiology / Classification

Primary Postpartum Hemorrhage (PPH) is an acute obstetric emergency characterized by excessive maternal blood loss occurring within the first 24 hours following childbirth.

Traditionally defined as:

≥500 mL blood loss after vaginal delivery
≥1,000 mL blood loss after cesarean delivery

Modern clinical frameworks increasingly define PPH as:

Any postpartum bleeding resulting in hemodynamic instability, requirement for transfusion, organ hypoperfusion, or significant maternal morbidity regardless of quantified blood loss.

Within the SCF framework, Primary Postpartum Hemorrhage is classified as:

A catastrophic postpartum hemostatic collapse syndrome characterized by failure of uterine vascular closure, coagulation instability, endothelial dysfunction, and systemic perfusion compromise resulting in acute maternal hemorrhagic shock risk.

SCF Classification

SCF Disease Category: Acute Hemostatic Failure Syndrome

SCF Functional Class:

Maternal Uterovascular Hemostasis Collapse Disorder

SCF Fault Tier Classification

Tier	Classification
Tier I	Hemostatic Regulatory Dysfunction
Tier II	Uterine Vascular Closure Failure
Tier III	Acute Hemorrhagic Instability
Tier IV	Systemic Perfusion Deficit
Tier V	Multiorgan Ischemic Injury
Tier VI	Hemorrhagic Shock and Maternal Collapse

Clinical Significance

Primary Postpartum Hemorrhage remains one of the leading causes of maternal morbidity and mortality worldwide.

Potential complications include:

Hemorrhagic shock
Disseminated intravascular coagulation (DIC)
Acute kidney injury
Hepatic injury
Myocardial ischemia
Pituitary ischemia (Sheehan syndrome)
Respiratory failure
Multiorgan dysfunction syndrome
Maternal death

SCF Domain Alignment

Primary Domains:

Hematologic
Vascular
Obstetric
Endothelial

Secondary Domains:

Renal
Cardiovascular
Hepatic
Neuroendocrine

2. ETIOPATHOGENIC CORE

Primary Cause

Primary Postpartum Hemorrhage develops through failure of physiologic postpartum hemostasis following placental separation.

The major etiologic mechanisms are classically summarized as the “4 Ts”:

Tone

Uterine atony

Trauma

Genital tract injury

Tissue

Retained placental tissue

Thrombin

Coagulation abnormalities

Key Drivers

Driver A — Uterine Atony

Accounts for the majority of cases.

Mechanism:

Failure of myometrial contraction
Persistent uterine blood flow
Open spiral arteries

Result:

Massive hemorrhage

Driver B — Birth Canal Trauma

Includes:

Cervical lacerations
Vaginal lacerations
Perineal injuries
Uterine rupture

Result:

Continued bleeding despite uterine contraction

Driver C — Retained Placental Tissue

Includes:

Placental fragments
Placenta accreta spectrum
Incomplete placental separation

Result:

Persistent vascular communication

Driver D — Coagulation Failure

Includes:

DIC
Severe thrombocytopenia
Coagulation factor deficiency

Result:

Inability to establish hemostasis

3. SCF FAULT ARCHITECTURE

SCF Tier	Fault Node	Consequence
Tier I	Hemostatic Activation Failure Node	Inadequate clot formation
Tier I	Endothelial Injury Node	Vascular instability
Tier II	Uterine Contractility Failure Node	Persistent uterine bleeding
Tier II	Placental Separation Failure Node	Ongoing vascular exposure
Tier III	Hemorrhagic Volume Loss Node	Circulatory instability
Tier III	Coagulopathy Amplification Node	Progressive bleeding
Tier IV	Perfusion Failure Node	Tissue hypoxia
Tier V	Organ Ischemia Node	Organ dysfunction
Tier VI	Hemorrhagic Shock Node	Maternal collapse

4. PATHOGENESIS FLOW (SCF LOGIC)

Delivery

↓

Placental Separation

↓

Failure of Physiologic Hemostasis

↓

Uterine Atony

and/or

Trauma

and/or

Retained Tissue

and/or

Coagulopathy

↓

Persistent Hemorrhage

↓

Acute Blood Loss

↓

Reduced Circulating Volume

↓

Compensatory Vasoconstriction

↓

Systemic Hypoperfusion

↓

Hemorrhagic Shock

↓

Multiorgan Dysfunction

↓

Maternal Mortality Risk

5. CLINICAL SPECTRUM

Stage	Clinical State	Characteristics
Stage 0	Hemostatic Vulnerability State	High-risk obstetric profile
Stage I	Mild Postpartum Bleeding	Stable hemodynamics
Stage II	Moderate Hemorrhage	Compensatory physiologic response
Stage III	Severe Hemorrhage	Hemodynamic instability
Stage IV	Massive Hemorrhage	Shock physiology emerging
Stage V	Hemorrhagic Shock Syndrome	Organ hypoperfusion
Stage VI	Refractory Maternal Collapse	Critical life-threatening state

6. SCF TRINITY FRAMEWORK MAPPING

Trinity Axis I — Structural Integrity

Affected Systems:

Uterus
Placental bed
Uterine vasculature
Birth canal tissues

Primary Failure:

Structural hemostatic closure failure

Trinity Axis II — Energetic Integrity

Affected Systems:

Cellular oxygen delivery
Mitochondrial ATP production
Organ perfusion systems

Primary Failure:

Oxygen and energy deprivation

Trinity Axis III — Informational Integrity

Affected Systems:

Coagulation signaling
Endothelial communication
Neurovascular regulation

Primary Failure:

Hemostatic signaling collapse

7. HEMORRHAGE EXPANSION MODULE

Clinical Subtype Registry

Type A

Uterine Atony Hemorrhage

Characteristics:

Most common subtype
Failure of uterine contraction

Type B

Traumatic Hemorrhage

Characteristics:

Genital tract injury
Surgical bleeding

Type C

Retained Tissue Hemorrhage

Characteristics:

Persistent placental vascular communication

Type D

Coagulopathic Hemorrhage

Characteristics:

Hemostasis failure
DIC association

Type E

Mixed-Mechanism Hemorrhage

Characteristics:

Multiple simultaneous causes

8. MULTI-OMICS PATHOGENESIS MAP

Omics Layer	SCF Interpretation
Genomics	Variants affecting coagulation, uterine contractility, vascular integrity, platelet function
Transcriptomics	Dysregulation of oxytocin signaling, inflammatory mediators, coagulation pathways
Proteomics	Coagulation factor depletion, endothelial injury proteins, platelet activation abnormalities
Metabolomics	Lactate accumulation, tissue hypoxia markers, shock-associated metabolic signatures
Epigenomics	Pregnancy-associated vascular adaptation instability
Interactomics	Oxytocin receptor, coagulation cascade, endothelial-hemostatic signaling disruption
Connectomics	Neurovascular regulation of postpartum uterine contraction
Biomechanicalomics	Uterine contractile failure and vascular compression loss

9. SCF PCR THERAPEUTIC STRATEGY

PREVENTATIVE

Objectives

Prevent postpartum hemorrhage before clinical onset.

Targets:

Uterine contractility
Placental management
Hemostatic readiness
Risk-factor identification

CURATIVE

Objectives

Rapid hemorrhage control and restoration of perfusion.

Targets:

Active bleeding
Coagulopathy
Hypovolemia
Organ hypoperfusion

Interventions:

Uterotonic therapy
Hemostatic resuscitation
Blood component replacement
Surgical hemorrhage control
Mechanical tamponade

RESTORATIVE

Objectives

Restore physiologic hemostasis and organ recovery.

Targets:

Endothelial repair
Coagulation normalization
Organ reperfusion recovery
Neuroendocrine stabilization

Potential strategies:

Precision hemostatic therapeutics
Endothelial regenerative platforms
SCF-derived hemorrhage resilience systems
Organ recovery optimization programs

10. CURRENT STANDARD OF CARE

Diagnostic Evaluation

Immediate Assessment

Quantified blood loss
Vital signs
Uterine tone assessment
Placental evaluation

Laboratory Evaluation

Complete blood count
Platelet count
PT/INR
aPTT
Fibrinogen
Lactate

Imaging

When indicated:

Pelvic ultrasound
CT angiography
Interventional radiology assessment

Treatment

First-Line Interventions

Uterine massage
Oxytocin administration
Uterotonic agents
Intravenous fluid resuscitation

Advanced Hemorrhage Control

Balloon tamponade
Compression sutures
Uterine artery embolization
Surgical exploration

Critical Care Management

Massive transfusion protocols
DIC management
Organ support
Intensive care monitoring

11. SCF THERAPEUTIC ENGINEERING OPPORTUNITIES

SCF Target Cluster A

Uterine Contractility Optimization Platform

Targets:

Oxytocin receptor pathways
Myometrial calcium signaling
Contractile synchronization

SCF Target Cluster B

Precision Hemostasis Platform

Targets:

Coagulation cascade regulation
Platelet activation systems
Fibrin stabilization

SCF Target Cluster C

Endothelial Recovery Platform

Targets:

Vascular integrity
Endothelial repair
Microvascular stabilization

SCF Target Cluster D

Organ Perfusion Protection Platform

Targets:

Ischemia-reperfusion injury
Mitochondrial resilience
Tissue oxygenation systems

12. TRANSLATIONAL BLUEPRINT

Diagnostic Biomarkers

Hemostatic

Fibrinogen
D-dimer
PT/INR
Platelet count

Perfusion

Lactate
Base deficit
Mixed venous oxygen saturation

Endothelial

von Willebrand factor
Thrombomodulin
Endothelial injury biomarkers

Organ Injury

Creatinine
ALT/AST
Cardiac troponins

Clinical Endpoints

Primary:

Hemorrhage control

Secondary:

Hemodynamic stabilization
Prevention of DIC
Organ preservation
Maternal survival

FDA Translational Pathway

Preclinical

↓

IND

↓

Phase I Safety

↓

Phase II Hemostatic Efficacy

↓

Phase III Maternal Outcomes

↓

NDA/BLA Submission

13. SCF DBI INTERPRETATION

Decentralized Biological Intelligence Failure

Cellular Layer

Coagulation, endothelial, and myometrial cells fail to coordinate effective hemostasis.

Tissue Layer

The placental bed remains functionally open despite delivery.

Organ Layer

The uterus loses its ability to generate adequate vascular compression and hemostatic closure.

System Layer

Hemodynamic, coagulation, and perfusion networks enter progressive instability.

Whole-Organism Layer

Maternal physiologic recovery after childbirth becomes overwhelmed by uncontrolled blood loss and systemic perfusion failure.

14. SCF LAYMAN’S SUMMARY

Primary Postpartum Hemorrhage is severe bleeding that occurs within the first 24 hours after childbirth and represents one of the most serious emergencies in obstetric medicine.

According to the SCF model, the condition develops when the uterus, blood vessels, placenta, and clotting systems fail to work together to stop bleeding after delivery. The resulting blood loss can rapidly lead to shock, organ injury, and death if not treated immediately.

Common warning signs include:

Heavy vaginal bleeding
Passing large blood clots
Dizziness
Rapid heartbeat
Low blood pressure
Weakness
Loss of consciousness in severe cases

Rapid recognition and aggressive treatment are critical because Primary Postpartum Hemorrhage is a time-sensitive, life-threatening condition.

SCF-RDOS INDICATION SUMMARY

Parameter	Classification
Disease	Primary Postpartum Hemorrhage (PPH)
Registry Code	SCF-RDOS-PPD-HM-001
Disease Type	Primary Postpartum Hemorrhage Syndrome
Adaptive Modules Activated	Hematologic + Vascular + Obstetric Emergency + Coagulation
SCF Fault Tier	I–VI
Primary Systems	Hematologic, Uterine, Vascular, Endothelial
Principal Fault Nodes	Uterine Contractility Failure, Hemostatic Collapse, Perfusion Failure
Mortality Risk	Very High Without Treatment
Morbidity Risk	Very High
Chronicity Risk	Low (Acute Event), High Sequelae Potential
SCF-PCR Applicability	Preventative, Curative, Restorative